|
BKNM-DP-169
N/A |
|
DSPE-PEG-antagonist Gµ°°×¾ÛÒÒ¶þ´¼Á×Ö¬
|
£¤Member visible
|
|
BKNM-DP-168
N/A |
|
DSPE-PEG-FPBA ¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-3-ôÈ»ù-4-·ú±½ÅðËá
|
£¤Member visible
|
|
BKNM-DP-167
N/A |
|
DSPE-PEG-HC ¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-7-ôÇ»ùÏã¶¹ËØ
|
£¤Member visible
|
|
BKNM-DP-165
N/A |
|
DSPE-hyd-PEG-AA PHÃô¸ÐÐÍÖ¬ÖÊÌå
|
£¤Member visible
|
|
BKNM-DP-164
N/A |
|
DSPE-PEG-Nitrobenzofurazan Á×Ö¬-¾ÛÒÒ¶þ´¼-Ïõ»ù±½²¢ß»à«
|
£¤Member visible
|
|
BKNM-DP-163
N/A |
|
DSPE-PEG-IA Á×Ö¬-¾ÛÒÒ¶þ´¼-µâÒÒõ£°·
|
£¤Member visible
|
|
BKNM-DP-162
N/A |
|
DSPE-PEG-Alexa Fluor Á×Ö¬-¾ÛÒÒ¶þ´¼-AlexaFluorÓ«¹âȾÁÏ
|
£¤Member visible
|
|
BKNM-DP-161
N/A |
|
Trastuzumab-PEG-DSPE ÇúÍ×Öéµ¥¿¹-¾ÛÒÒ¶þ´¼-¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·
|
£¤Member visible
|
|
BKNM-DP-160
N/A |
|
DSPE-PEG-SWCNTs Á×Ö¬¾ÛÒÒ¶þ´¼Ì¼ÄÉÃ×¹Ü
|
£¤Member visible
|
|
BKNM-DP-159
N/A |
|
DSPE-PEG-SP2-AA¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-SP2-AA
|
£¤Member visible
|
|
BKNM-DP-158
N/A |
|
DSPE-PEG 2000-TM Á×Ö¬¾ÛÒÒ¶þ´¼-Ѫ˨µ÷½Úµ°°×
|
£¤Member visible
|
|
BKNM-DP-157
N/A |
|
anti-HER2 scFv-PEG-DSPE µ¥Á´¿¹ÌåÖ¬ÖÊÌåÖÆ±¸
|
£¤Member visible
|
|
BKNM-DP-157
N/A |
|
anti-HER2 scFv-PEG-DSPE µ¥Á´¿¹ÌåÖ¬ÖÊÌåÖÆ±¸
|
£¤Member visible
|
|
BKNM-DP-156
N/A |
|
SPE-PEG-SG¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-SG
|
£¤Member visible
|
|
BKNM-DP-155
N/A |
|
DSPE-PEG-Thrombomodulin¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-¿¹Ìå
|
£¤Member visible
|
|
BKNM-DP-154
N/A |
|
DSPE-PEG-OVA¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-ova
|
£¤Member visible
|
|
BKNM-DP-153
N/A |
|
DSPE-PEG2000-PSP¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-PSP
|
£¤Member visible
|
|
BKNM-DP-152
N/A |
|
DSPE-PEG-Riboflavin¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-ºË»ÆËØ
|
£¤Member visible
|
|
BKNM-DP-152
N/A |
|
DSPE-PEG-Riboflavin¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-ºË»ÆËØ
|
£¤Member visible
|
|
BKNM-DP-151
N/A |
|
DSPE-PEG-NPC ¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-NPC
|
£¤Member visible
|
|
BKNM-DP-150
N/A |
|
DSPE-PEG-SG¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-SG
|
£¤Member visible
|
|
BKNM-DP-149
N/A |
|
DSPE-PEG-Bodipy ¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼ -·ú»¯Åð¶þßÁ¿©£¨Ó«¹âȾÁÏ£©
|
£¤Member visible
|
|
BKNM-DP-148
N/A |
|
DSPE-PEG-IR825¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-½üºìÍâȾÁÏ
|
£¤Member visible
|
|
BKNM-DP-147
N/A |
|
DSPE-PEG2000-VS¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-VS
|
£¤Member visible
|
|
BKNM-DP-146
N/A |
|
GSH-PEG-DSPE¹Èë׸ÊëÄ-¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼
|
£¤Member visible
|
|
BKNM-DP-145
N/A |
|
Apt-PEG2000-DSPE¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-Apt
|
£¤Member visible
|
|
BKNM-DP-144
N/A |
|
DSPE-PEG-Rapamycin¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-À×ÅÁÃ¹ËØ
|
£¤Member visible
|
|
BKNM-DP-143
N/A |
|
DSPE-PEG(2000)-cyclopamine Á×Ö¬-¾ÛÒÒ¶þ´¼-»·°Í°·
|
£¤Member visible
|
|
BKNM-DP-142
N/A |
|
DSPE-PEG-Cholic acid Á×Ö¬-¾ÛÒÒ¶þ´¼-µ¨Ëá
|
£¤Member visible
|
|
BKNM-DP-141
N/A |
|
DSPE-PEG-RVG¶¨ÖƶþÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-¿ñÈ®²¡²¡¶¾Ìǵ°°×
|
£¤Member visible
|
|
BKNM-DP-140
N/A |
|
¶þÓ²Ö¬õ£»ùÁ×Ö¬õ£ÒÒ´¼°·-¾ÛÒÒ¶þ´¼-ÔÐͪ DSPE-PEG-progesterone
|
£¤Member visible
|
|
BKNM-DP-139
N/A |
|
DSPE-PEG-Ce6 Á×Ö¬-¾ÛÒÒ¶þ´¼-¹âÃô¼Á
|
£¤Member visible
|